ArticleFrontiers in immunology2025
A tumor immune microenvironment gene expression signature for predicting prognosis, immunotherapy efficacy, and drug candidates in triple-negative breast cancer.
Li Bai et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.